Intra-Alveolar Gelatin Sponge Delivery of Dexamethasone vs. Methylprednisolone After Mandibular Third-Molar Surgery: A Randomized Controlled Trial
Applied Sciences · 21.04.2026 · 16 (8) · 4060
DOI: 10.3390/app16084060 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Applied Sciences, online erschienen am 21.04.2026. Verfasst von Shabnam Sahebpanah und 4 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Impacted mandibular third-molar surgery commonly causes early postoperative pain, swelling, and trismus. This randomized, controlled, three-arm parallel trial evaluated whether intra-alveolar corticosteroid delivery via an absorbable gelatin sponge improves postoperative recovery compared with a saline control. Fifty-five patients were assessed for eligibility; 37 healthy adults (18–35 years) undergoing standardized mandibular third-molar extraction were randomized to dexamethasone 8 mg (Decort®), methylprednisolone 40 mg (Prednol®), or control (saline), all applied intra-alveolarly using a gelatin sponge carrier. Doses were selected using standard systemic glucocorticoid equivalence tables as a pragmatic potency reference, acknowledging unknown intra-alveolar pharmacokinetics/bioavailability. The prespecified primary endpoint (used for sample size planning) was postoperative Day 1 VAS pain; key secondary endpoints were Day 1 analgesic consumption and Day 3 facial swelling. Pain (VAS), analgesic use, trismus, and facial swelling (tragus–pogonion, tragus–labial commissure, and angulus–canthus distances) were assessed on postoperative Days 1, 2, 3, and 7 by a blinded evaluator. Two participants in the methylprednisolone group did not attend postoperative visits. To address potential attrition bias, an Intention-to-Treat (ITT) sensitivity analysis using conservative control-median imputation was performed alongside the available-case analyses. A global False Discovery Rate (FDR) correction was also applied to control for multiplicity. In both analyses, the steroid groups showed lower Day 1 pain scores than the control group. Methylprednisolone was associated with lower Day 3 swelling values than control for the tragus–pogonion and angulus–canthus measurements. These findings should be interpreted as preliminary, given the small sample size, linear swelling measurements, and lack of blinding verification.
Zitieren
APA
Sahebpanah, S., Elver, A., Caymaz, M. G., Kıbcak, E., & Ghane, M. G. (2026). Intra-Alveolar Gelatin Sponge Delivery of Dexamethasone vs. Methylprednisolone After Mandibular Third-Molar Surgery: A Randomized Controlled Trial. Applied Sciences, 16(8), 4060. https://doi.org/10.3390/app16084060
Vancouver
Sahebpanah S, Elver A, Caymaz MG, Kıbcak E, Ghane MG. Intra-Alveolar Gelatin Sponge Delivery of Dexamethasone vs. Methylprednisolone After Mandibular Third-Molar Surgery: A Randomized Controlled Trial. Applied Sciences. 2026;16(8):4060. doi:10.3390/app16084060
BibTeX
@article{Sahebpanah2026,
author = {Sahebpanah, Shabnam and Elver, Atalay and Caymaz, Mehmet Gagari and Kıbcak, Erdoğan and Ghane, Melika Ghasemi},
title = {Intra-Alveolar Gelatin Sponge Delivery of Dexamethasone vs. Methylprednisolone After Mandibular Third-Molar Surgery: A Randomized Controlled Trial},
journal = {Applied Sciences},
year = {2026},
volume = {16},
number = {8},
pages = {4060},
doi = {10.3390/app16084060}
}
EUVIMED